APA

VanderVen B. C., Fahey R. J., Lee W., Liu Y., Abramovitch R. B., Memmott C., Crowe A. M., Eltis L. D., Perola E., Deininger D. D., Wang T., Locher C. P. & Russell D. G. (20160129). Novel inhibitors of cholesterol degradation in Mycobacterium tuberculosis reveal how the bacterium's metabolism is constrained by the intracellular environment. : PLoS pathogens.

Chicago

VanderVen Brian C, Fahey Ruth J, Lee Wonsik, Liu Yancheng, Abramovitch Robert B, Memmott Christine, Crowe Adam M, Eltis Lindsay D, Perola Emanuele, Deininger David D, Wang Tiansheng, Locher Christopher P and Russell David G. 20160129. Novel inhibitors of cholesterol degradation in Mycobacterium tuberculosis reveal how the bacterium's metabolism is constrained by the intracellular environment. : PLoS pathogens.

Harvard

VanderVen B. C., Fahey R. J., Lee W., Liu Y., Abramovitch R. B., Memmott C., Crowe A. M., Eltis L. D., Perola E., Deininger D. D., Wang T., Locher C. P. and Russell D. G. (20160129). Novel inhibitors of cholesterol degradation in Mycobacterium tuberculosis reveal how the bacterium's metabolism is constrained by the intracellular environment. : PLoS pathogens.

MLA

VanderVen Brian C, Fahey Ruth J, Lee Wonsik, Liu Yancheng, Abramovitch Robert B, Memmott Christine, Crowe Adam M, Eltis Lindsay D, Perola Emanuele, Deininger David D, Wang Tiansheng, Locher Christopher P and Russell David G. Novel inhibitors of cholesterol degradation in Mycobacterium tuberculosis reveal how the bacterium's metabolism is constrained by the intracellular environment. : PLoS pathogens. 20160129.